NCT02949661

Brief Summary

Tracheal resection and reconstruction (TRR) is the treatment of choice for most patients with tracheal stenosis or tracheal tumors .The postintubation tracheal stenosis is the common indication for (TRR).The immediate postoperative period can be anxiety provoking for some reasons such as requirement to maintain a flexed neck, oxygen mask, and surgical pain which inadequately treated. Bilateral superficial cervical plexus block (BSCPB) is a popular regional anesthesia technique for its feasibility and efficacy. The use of regional anesthesia in combination with general anesthesia may lighten the level of general anesthesia required , provide prolonged postoperative analgesia and reduce the requirements for opioid analgesics Local anesthetic infiltration into the surgical incision can relieve pain at the wound site after surgery, as part of multimodal analgesic approach. Levobupivacaine, is "S"-enantiomer of bupivacaine, has strongly emerged as a safer alternative for regional anesthesia than bupivacaine . Levobupivacaine has been found to be equally efficacious as bupivacaine, but with a superior pharmacokinetic profile. Clinically, levobupivacaine has been observed to be well tolerated in regional anesthesia techniques both after bolus administration and continuous post-operative infusion.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 31, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

September 11, 2020

Status Verified

September 1, 2020

Enrollment Period

6 months

First QC Date

October 27, 2016

Last Update Submit

September 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain score

    Postoperative pain scores will be assessed using postoperative visual analogue score

    For 24 hours after surgery

Secondary Outcomes (9)

  • Systolic blood pressure

    For 4 hours after start of surgery

  • Diastolic blood pressure

    For 4 hours after start of surgery

  • Heart rate

    For 4 hours after start of surgery

  • Peripheral oxygen saturation

    For 4 hours after start of surgery

  • End-tidal Carbon dioxide tension

    For 4 hours after start of surgery

  • +4 more secondary outcomes

Study Arms (2)

Superficial cervical plexus block

EXPERIMENTAL

Patients will receive bilateral superficial cervical plexus block using levobupivacaine

Procedure: Superficial cervical plexus block

Local wound infiltration

ACTIVE COMPARATOR

Patients will receive local wound infiltration with levobupivacaine after the conclusion of surgery

Procedure: Local wound infiltration

Interventions

Patients will receive bilateral superficial cervical plexus block

Superficial cervical plexus block

Patients will receive local wound infiltration

Local wound infiltration

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists physical class status I or II
  • Undergoing elective upper tracheal resection and reconstruction surgery

You may not qualify if:

  • Age less than18 years
  • Patients with preoperative medication included opioid
  • History of allergy to the drugs used
  • Coagulation disorders
  • Pregnancy
  • Patient refusal
  • Local sepsis
  • Inability to understand the study protocol or pain scale.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Hanaa M Elbendary, MD

    Department of Anaesthesia, Surgical Intensive Care and Pain Medicine, College of Medicine, Mansoura University, Mansoura, Egypt

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2016

First Posted

October 31, 2016

Study Start

September 1, 2016

Primary Completion

March 1, 2017

Study Completion

May 1, 2017

Last Updated

September 11, 2020

Record last verified: 2020-09